Evaluation of the Safety, Tolerability and Pharmacokinetics of HY8931 in Healthy Adult Participants

NCT07281703 · clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
60
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Newsoara Biopharma Co., Ltd.